References | Age (years) | Gender | Microbiologic findings | Treatment of PTA prior to NF development | Outcome | |
---|---|---|---|---|---|---|
Surgery | Antibiotics | |||||
Wills [42] | 35 | M | S. maltophilia; VGS; B. melaninogenicus | Spon perf | Iv. pen | Survived |
Wenig [43] | 50 | M | AHS; F. nucleatum; E. lentum; B. melaninogenicus; P. anaerobius; E. cloacae; S. epidermidis; Klebsiella spp.; P. aeruginosa | Simultaneousa | Â | Died |
Wenig [63] | 50 | M | AHS; E. coli; mitis group strep.; S. san-guis; S. faecalis; B. fragilis; B. mela-ninogenicus; Corynebacterium spp. | Incision | Iv. cefazolin | Died |
Pedersen [37] | 67 | M | No cultures | Simultaneousa | Â | Died |
Lalwani [44] | 33 | M | GCS; B. melaninogenicus | Incision | Im. pen | Survived |
Tovi [43] | 20 | M | Enterobacter spp.; P. mirabilis; K. pneumoniae | NIb | Â | Died |
Scott [46] | 51 | M | Milleri group strep; NHS; anaerobes | Drainage | Iv. cefo, fluclo, metro | Survived |
Maisel [50] | 29 | M | VGS | NIb | Â | Survived |
Jackson [47] | 63 | M | E. lentum; P. anaerobius; B. fragilis | Drainage | None | Survived |
Greinwald [45] | 65 | M | GAS; S. epidermidis | Incision | Iv. ampicillin | Survived |
Hadfield [48] | 53 | M | GCS; Bacteroides spp. | Incision | Iv. cefo, metro | Survived |
Skitalic [51] | 50 | F | S. epidermidis; (GAS antibodies) | Simultaneousa | Â | Survived |
Djupesland [52] | 39 | M | GAS | Simultaneousa | Â | Died |
Djupesland [52] | 36 | M | Milleri group strep.; Bacteroides spp. | Asp | Iv. pen, tobra, metro | Survived |
Nielsen [58] | NI | NI | GCS | NIb | Â | Died |
Safak [49] | 43 | F | GAS; CNS; Enterococci | Drainage | Iv. pen, im. chlor | Survived |
Goldenberg [53] | 53 | F | BHS | Incision | Iv. pen → pip-tazo | Survived |
Vaid [61] | 55 | M | GAS | Simultaneousa | Â | Survived |
Beninsegna [41] | 58 | M | S. epidermidis | Acute tons | Iv. ampicillin, metro | Survived |
Beninsegna [41] | 80 | M | GAS; Peptostreptococcus spp.; C. albicans | Incision | Iv. ampicillin, metro | Survived |
Losanoff [54] | 54 | M | NHS; Peptostreptococcus spp. | No | Iv. ceftriaxo-ne, amoxicillin | Survived |
Bono [55] | 60 | M | No cultures | Spon perf | Iv. ceftriaxo-rine, metro | Died |
Wolf [57] | 62 | M | GAS | NIb | Â | Survived |
Wolf [57] | 49 | M | NHS | NIb | Â | Survived |
Andres [56] | 87 | F | Staphylococci | NIb | Â | Survived |
Andres [56] | 64 | F | Staphylococci; Gram-negative rod | NIb | Â | Survived |
Andres [56] | 44 | M | Staphylococci; Gram-negative rod; C. albicans | NIb | Â | Survived |
Andres [56] | 44 | M | Staphylococci; Gram-negative rod; C. albicans | NIb | Â | Survived |
Horváth [59] | 55 | M | No bacterial growth | NIb |  | Survived |
Horváth [59] | 61 | F | Parvimonas micra | NIb |  | Survived |
Flores [62] | 38 | M | S. constellatus, Peptostreptococcus spp., Prevotella spp. | Simultaneousa | Â | Survived |
Brown [64] | 56 | M | Prevotella spp; CNS | Incision | Clindamycin | Survived |
Irani [66] | 33 | M | S. aureus | Incision | Iv. antibiotics | Survived |
Burstin [65] | 47 | F | Milleri group strep.; anaerobes | No | Iv. antibiotics | Survived |